{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T02:22:46Z","timestamp":1771467766809,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006578","name":"Chi Mei Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006578","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.transproceed.2020.02.145","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T20:51:22Z","timestamp":1593809482000},"page":"1869-1874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Ibudilast, a Phosphodiesterase Inhibitor and Toll-Like Receptor-4 Antagonist, Improves Hemorrhagic Shock and Reperfusion-Induced Left Ventricular Dysfunction by Reducing Myocardial Tumor Necrosis Factor \u03b1"],"prefix":"10.1016","volume":"52","author":[{"given":"Nan-Chun","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiun-Jr","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2020.02.145_bib1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.injury.2011.05.032","article-title":"The role of toll-like receptor-4 in the development of multi-organ failure following traumatic haemorrhagic shock and resuscitation","volume":"43","author":"McGhan","year":"2012","journal-title":"Injury"},{"key":"10.1016\/j.transproceed.2020.02.145_bib2","first-page":"545","article-title":"Outcome after hemorrhagic shock in trauma patients","volume":"45","author":"Heckbert","year":"1998","journal-title":"J\u00a0Trauma"},{"key":"10.1016\/j.transproceed.2020.02.145_bib3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/SHK.0000000000000155","article-title":"Toll-like receptor 4 plays a central role in cardiac dysfunction during trauma hemorrhage shock","volume":"42","author":"Zhang","year":"2014","journal-title":"Shock"},{"key":"10.1016\/j.transproceed.2020.02.145_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5415\/apallergy.2015.5.1.51","article-title":"Oral antiplatelet agent hypersensitivity and cross-reactivity managed by successful desensitisation","volume":"5","author":"Chin","year":"2015","journal-title":"Asia Pac Allergy"},{"key":"10.1016\/j.transproceed.2020.02.145_bib5","doi-asserted-by":"crossref","first-page":"e2234","DOI":"10.1038\/cddis.2016.140","article-title":"The emerging role of toll-like receptor 4 in myocardial inflammation","volume":"7","author":"Yang","year":"2016","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.transproceed.2020.02.145_bib6","first-page":"415","article-title":"Effects of ibudilast on calcium deposition in soft tissues of rabbits with atherosclerosis","volume":"18","author":"Yasui","year":"1990","journal-title":"J\u00a0Int Med Res"},{"key":"10.1016\/j.transproceed.2020.02.145_bib7","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1089\/neu.2011.1863","article-title":"The antinociceptive effect of the asthma drug ibudilast in rat models of peripheral and central neuropathic pain","volume":"29","author":"Hama","year":"2012","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.transproceed.2020.02.145_bib8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.brainres.2003.08.028","article-title":"Ibudilast, a phosphodiesterase inhibitor, protects against white matter damage under chronic cerebral hypoperfusion in the rat","volume":"992","author":"Wakita","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.transproceed.2020.02.145_bib9","doi-asserted-by":"crossref","first-page":"R600","DOI":"10.1152\/ajpregu.00182.2004","article-title":"Signaling for myocardial depression in hemorrhagic shock: roles of Toll-like receptor 4 and p55 TNF-alpha receptor","volume":"288","author":"Meng","year":"2005","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.transproceed.2020.02.145_bib10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/phrs.1998.0463","article-title":"The role of TNF in cardiovascular disease","volume":"40","author":"Ferrari","year":"1999","journal-title":"Pharmacol Res"},{"issue":"Suppl 1","key":"10.1016\/j.transproceed.2020.02.145_bib11","first-page":"I270","article-title":"Inhibition of toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury","volume":"114","author":"Shimamoto","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.transproceed.2020.02.145_bib12","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2147\/IJGM.S33416","article-title":"Genomics in cardiovascular diseases: analysis of the importance of the toll-like receptor signaling pathway","volume":"5","author":"Bustamante","year":"2012","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.transproceed.2020.02.145_bib13","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/01.CIR.93.4.704","article-title":"Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart","volume":"93","author":"Torre-Amione","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.transproceed.2020.02.145_bib14","volume":"7","author":"Carlsson","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.transproceed.2020.02.145_bib15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1615\/CritRevEukarGeneExpr.v20.i2.10","article-title":"Tumor necrosis factor-alpha signaling in macrophages","volume":"20","author":"Parameswaran","year":"2010","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"10.1016\/j.transproceed.2020.02.145_bib16","doi-asserted-by":"crossref","first-page":"F1005","DOI":"10.1152\/ajprenal.00535.2016","article-title":"Tumor necrosis factor-alpha, kidney function, and hypertension","volume":"313","author":"Mehaffey","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.transproceed.2020.02.145_bib17","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1227\/01.NEU.0000365771.89576.77","article-title":"Ibudilast inhibits cerebral aneurysms by down-regulating inflammation-related molecules in the vascular wall of rats","volume":"66","author":"Yagi","year":"2010","journal-title":"Neurosurgery"},{"key":"10.1016\/j.transproceed.2020.02.145_bib18","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1111\/bph.14777","article-title":"Ibudilast attenuates doxorubicin-induced cytotoxicity by suppressing formation of TRPC3 channel and NADPH oxidase 2 protein complexes","volume":"176","author":"Nishiyama","year":"2019","journal-title":"Br J Pharmacol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134520302396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134520302396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:37:12Z","timestamp":1758577032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134520302396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0041134520302396"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2020.02.145","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ibudilast, a Phosphodiesterase Inhibitor and Toll-Like Receptor-4 Antagonist, Improves Hemorrhagic Shock and Reperfusion-Induced Left Ventricular Dysfunction by Reducing Myocardial Tumor Necrosis Factor \u03b1","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2020.02.145","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}